248 related articles for article (PubMed ID: 31155833)
1. Allocation to highly sensitized patients based on acceptable mismatches results in low rejection rates comparable to nonsensitized patients.
Heidt S; Haasnoot GW; Witvliet MD; van der Linden-van Oevelen MJH; Kamburova EG; Wisse BW; Joosten I; Allebes WA; van der Meer A; Hilbrands LB; Baas MC; Spierings E; Hack CE; van Reekum FE; van Zuilen AD; Verhaar MC; Bots ML; Drop ACAD; Plaisier L; Seelen MAJ; Sanders JS; Hepkema BG; Lambeck AJA; Bungener LB; Roozendaal C; Tilanus MGJ; Voorter CE; Wieten L; van Duijnhoven EM; Gelens MACJ; Christiaans MHL; van Ittersum FJ; Nurmohamed SA; Lardy NM; Swelsen W; van der Pant KAMI; van der Weerd NC; Ten Berge IJM; Bemelman FJ; Hoitsma A; van der Boog PJM; de Fijter JW; Betjes MGH; Otten HG; Roelen DL; Claas FHJ
Am J Transplant; 2019 Oct; 19(10):2926-2933. PubMed ID: 31155833
[TBL] [Abstract][Full Text] [Related]
2. Kidney allocation based on proven acceptable antigens results in superior graft survival in highly sensitized patients.
Heidt S; Haasnoot GW; van Rood JJ; Witvliet MD; Claas FHJ
Kidney Int; 2018 Feb; 93(2):491-500. PubMed ID: 28947279
[TBL] [Abstract][Full Text] [Related]
3. Highly Sensitized Patients Are Well Served by Receiving a Compatible Organ Offer Based on Acceptable Mismatches.
Heidt S; Haasnoot GW; van der Linden-van Oevelen MJH; Claas FHJ
Front Immunol; 2021; 12():687254. PubMed ID: 34248971
[TBL] [Abstract][Full Text] [Related]
4. The quest to decipher HLA immunogenicity: Telling friend from foe.
Tambur AR; McDowell H; Hod-Dvorai R; Abundis MAC; Pinelli DF
Am J Transplant; 2019 Oct; 19(10):2910-2925. PubMed ID: 31165546
[TBL] [Abstract][Full Text] [Related]
5. Specificity, strength, and evolution of pretransplant donor-specific HLA antibodies determine outcome after kidney transplantation.
Senev A; Lerut E; Van Sandt V; Coemans M; Callemeyn J; Sprangers B; Kuypers D; Emonds MP; Naesens M
Am J Transplant; 2019 Nov; 19(11):3100-3113. PubMed ID: 31062492
[TBL] [Abstract][Full Text] [Related]
6. How the definition of acceptable antigens and epitope analysis can facilitate transplantation of highly sensitized patients with excellent long-term graft survival.
Heidt S; Haasnoot GW; Claas FHJ
Curr Opin Organ Transplant; 2018 Aug; 23(4):493-499. PubMed ID: 29846197
[TBL] [Abstract][Full Text] [Related]
7. Histological picture of antibody-mediated rejection without donor-specific anti-HLA antibodies: Clinical presentation and implications for outcome.
Senev A; Coemans M; Lerut E; Van Sandt V; Daniëls L; Kuypers D; Sprangers B; Emonds MP; Naesens M
Am J Transplant; 2019 Mar; 19(3):763-780. PubMed ID: 30107078
[TBL] [Abstract][Full Text] [Related]
8. Value of monitoring circulating donor-reactive memory B cells to characterize antibody-mediated rejection after kidney transplantation.
Luque S; Lúcia M; Melilli E; Lefaucheur C; Crespo M; Loupy A; Bernal-Casas D; Gomà M; Jarque M; Crespo E; Montero N; Manonelles A; Cruzado JM; Gil-Vernet S; Grinyó JM; Bestard O
Am J Transplant; 2019 Feb; 19(2):368-380. PubMed ID: 30085394
[TBL] [Abstract][Full Text] [Related]
9. Impact of HLA compatibility in recipients of kidneys from expanded criteria donors: A Collaborative Transplant Study Report.
Echterdiek F; Latus J; Döhler B; Schwenger V; Süsal C
Int J Immunogenet; 2021 Apr; 48(2):201-210. PubMed ID: 32945128
[TBL] [Abstract][Full Text] [Related]
10. Kidney transplantation in the United States.
Cecka JM
Clin Transpl; 2008; ():1-18. PubMed ID: 19711510
[TBL] [Abstract][Full Text] [Related]
11. The 25th anniversary of the Eurotransplant Acceptable Mismatch program for highly sensitized patients.
Heidt S; Witvliet MD; Haasnoot GW; Claas FH
Transpl Immunol; 2015 Oct; 33(2):51-7. PubMed ID: 26325207
[TBL] [Abstract][Full Text] [Related]
12. The PROCARE consortium: toward an improved allocation strategy for kidney allografts.
Otten HG; Joosten I; Allebes WA; van der Meer A; Hilbrands LB; Baas M; Spierings E; Hack CE; van Reekum F; van Zuilen AD; Verhaar MC; Bots ML; Seelen MA; Sanders JS; Hepkema BG; Lambeck AJ; Bungener LB; Roozendaal C; Tilanus MG; Vanderlocht J; Voorter CE; Wieten L; van Duijnhoven E; Gelens M; Christiaans M; van Ittersum F; Nurmohamed A; Lardy NM; Swelsen WT; van Donselaar-van der Pant KA; van der Weerd NC; Ten Berge IJ; Bemelman FJ; Hoitsma AJ; de Fijter JW; Betjes MG; Roelen DL; Claas FH
Transpl Immunol; 2014 Oct; 31(4):184-90. PubMed ID: 25258025
[TBL] [Abstract][Full Text] [Related]
13. Donor-Recipient Matching Based on Predicted Indirectly Recognizable HLA Epitopes Independently Predicts the Incidence of De Novo Donor-Specific HLA Antibodies Following Renal Transplantation.
Lachmann N; Niemann M; Reinke P; Budde K; Schmidt D; Halleck F; Pruß A; Schönemann C; Spierings E; Staeck O
Am J Transplant; 2017 Dec; 17(12):3076-3086. PubMed ID: 28613392
[TBL] [Abstract][Full Text] [Related]
14. Renal transplantation of highly sensitised patients via prioritised renal allocation programs. Shorter waiting time and above-average graft survival.
De Meester J; Doxiadis II; Persijn GG; Claas FH
Nephron; 2002 Sep; 92(1):111-9. PubMed ID: 12187093
[TBL] [Abstract][Full Text] [Related]
15. Eplet Mismatch Load and
Senev A; Coemans M; Lerut E; Van Sandt V; Kerkhofs J; Daniëls L; Driessche MV; Compernolle V; Sprangers B; Van Loon E; Callemeyn J; Claas F; Tambur AR; Verbeke G; Kuypers D; Emonds MP; Naesens M
J Am Soc Nephrol; 2020 Sep; 31(9):2193-2204. PubMed ID: 32764139
[TBL] [Abstract][Full Text] [Related]
16. Alloantibody Responses After Renal Transplant Failure Can Be Better Predicted by Donor-Recipient HLA Amino Acid Sequence and Physicochemical Disparities Than Conventional HLA Matching.
Kosmoliaptsis V; Mallon DH; Chen Y; Bolton EM; Bradley JA; Taylor CJ
Am J Transplant; 2016 Jul; 16(7):2139-47. PubMed ID: 26755448
[TBL] [Abstract][Full Text] [Related]
17. Impact of HLA mismatch at first kidney transplant on lifetime with graft function in young recipients.
Foster BJ; Dahhou M; Zhang X; Platt RW; Smith JM; Hanley JA
Am J Transplant; 2014 Apr; 14(4):876-85. PubMed ID: 24612783
[TBL] [Abstract][Full Text] [Related]
18. Center-defined unacceptable HLA antigens facilitate transplants for sensitized patients in a multi-center kidney exchange program.
Baxter-Lowe LA; Cecka M; Kamoun M; Sinacore J; Melcher ML
Am J Transplant; 2014 Jul; 14(7):1592-8. PubMed ID: 24934640
[TBL] [Abstract][Full Text] [Related]
19. Root cause analysis of limitations of virtual crossmatch for kidney allocation to highly-sensitized patients.
Jani V; Ingulli E; Mekeel K; Morris GP
Hum Immunol; 2017 Feb; 78(2):72-79. PubMed ID: 27864154
[TBL] [Abstract][Full Text] [Related]
20. The results of HLA-incompatible kidney transplantation according to pre-transplant crossmatch tests: Donor-specific antibody as a prominent predictor of acute rejection.
Kwon H; Kim YH; Kim JY; Choi JY; Shin S; Jung JH; Park SK; Han DJ
Clin Transplant; 2019 May; 33(5):e13533. PubMed ID: 30864255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
